Bioextrax AB (publ)

Stockholm Stock Exchange BIOEX.ST

Bioextrax AB (publ) Net Cash Used Provided By Financing Activities for the year ending December 31, 2023: USD 1.01 M

Bioextrax AB (publ) Net Cash Used Provided By Financing Activities is USD 1.01 M for the year ending December 31, 2023, a -75.26% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.
  • Bioextrax AB (publ) Net Cash Used Provided By Financing Activities for the year ending December 31, 2022 was USD 4.10 M, a 127.40% change year over year.
  • Bioextrax AB (publ) Net Cash Used Provided By Financing Activities for the year ending December 31, 2021 was USD 1.80 M, a 156.91% change year over year.
  • Bioextrax AB (publ) Net Cash Used Provided By Financing Activities for the year ending December 31, 2020 was USD 701.85 K, a 125.44% change year over year.
  • Bioextrax AB (publ) Net Cash Used Provided By Financing Activities for the year ending December 31, 2019 was USD 311.32 K, a 179.28% change year over year.
Key data
Date Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure Effect Of Forex Changes On Cash
Market news
SV Wall Street
Stockholm Stock Exchange: BIOEX.ST

Bioextrax AB (publ)

CEO Mr. Edvard Hall
IPO Date April 28, 2020
Location Sweden
Headquarters Skiffervägen 76
Employees 13
Sector Health Care
Industries
Biotechnology Oil Extraction Paper & Forest Products
Description

Bioextrax AB (publ) develops and commercializes a bio-based extraction platform technology. It harvests bioplastics (PHA) granules, organic hydrolyzed protein, keratin fibers, bio-oils, protein-rich by products, and amino acids from bacteria. The company was incorporated in 2014 and is based in Lund, Sweden.

StockViz Staff

February 5, 2025

Any question? Send us an email